Predictive Oncology Correlations
POAI Stock | USD 0.83 0.02 2.35% |
The current 90-days correlation between Predictive Oncology and Global E Online is 0.15 (i.e., Average diversification). The correlation of Predictive Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Predictive Oncology Correlation With Market
Good diversification
The correlation between Predictive Oncology and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and DJI in the same portfolio, assuming nothing else is changed.
Predictive | Build AI portfolio with Predictive Stock |
Moving together with Predictive Stock
0.72 | TFX | Teleflex Incorporated | PairCorr |
0.75 | GCTK | GlucoTrack | PairCorr |
0.78 | MMSI | Merit Medical Systems | PairCorr |
0.83 | NEOG | Neogen | PairCorr |
0.85 | TMCI | Treace Medical Concepts | PairCorr |
0.69 | DYAI | Dyadic International | PairCorr |
Moving against Predictive Stock
0.59 | MASS | 908 Devices | PairCorr |
0.59 | MBOT | Microbot Medical | PairCorr |
0.49 | CAH | Cardinal Health | PairCorr |
0.46 | MODV | ModivCare | PairCorr |
0.45 | DH | Definitive Healthcare | PairCorr |
0.43 | NVNO | enVVeno Medical Corp | PairCorr |
0.4 | XTNT | Xtant Medical Holdings | PairCorr |
0.4 | HSCSW | Heart Test Laboratories | PairCorr |
0.36 | FIGS | Figs Inc | PairCorr |
0.34 | RDNT | RadNet Inc | PairCorr |
0.33 | HIMS | Hims Hers Health Aggressive Push | PairCorr |
0.31 | NYXH | Nyxoah | PairCorr |
0.64 | DNA | Ginkgo Bioworks Holdings Trending | PairCorr |
0.57 | SLS | Sellas Life Sciences | PairCorr |
0.56 | DRTS | Alpha Tau Medical | PairCorr |
0.53 | NVS | Novartis AG ADR | PairCorr |
0.52 | ADUS | Addus HomeCare | PairCorr |
0.48 | STRM | Streamline Health | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Predictive Stock performing well and Predictive Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Predictive Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
GLBE | 2.60 | (0.02) | 0.00 | 0.28 | 0.00 | 4.52 | 40.17 | |||
CVI | 2.70 | 0.83 | 0.22 | 10.10 | 2.93 | 6.03 | 19.44 | |||
SE | 2.20 | 0.26 | 0.04 | (3.27) | 3.52 | 3.26 | 18.71 | |||
IPG | 1.74 | 0.00 | (0.04) | 0.05 | 2.43 | 3.32 | 16.40 | |||
DK | 3.13 | 0.72 | 0.12 | (6.91) | 4.12 | 8.37 | 21.30 | |||
STGW | 2.99 | (0.29) | 0.00 | 1.05 | 0.00 | 5.27 | 24.48 | |||
CDW | 1.76 | 0.22 | 0.04 | (3.31) | 2.39 | 3.49 | 17.23 | |||
TITN | 2.49 | 0.36 | 0.09 | 3.43 | 2.86 | 4.74 | 17.04 |
Predictive Oncology Corporate Management
Joshua MBA | Interim Officer | Profile | |
BS BSc | VP RD | Profile | |
Pamela MBA | Chief Officer | Profile | |
Raymond Vennare | CEO Chairman | Profile | |
DSc OD | VP Operations | Profile | |
Julia Kirshner | Chief Officer | Profile |